Tag: Treatment

biocryst-presents-new-real-world-evidence-showing-reductions-in-attack-rates-in-hae-patients-with-normal-c1-inhibitor-after-beginning-orladeyo-berotralstat-treatment

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with...

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) TreatmentIn a recent presentation...
pharming-group-provides-update-on-ongoing-regulatory-review-of-leniolisib-for-the-treatment-of-apds-in-the-european-union

Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of...

Pharming Group Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of APDS in the European UnionLeiden, the Netherlands, May 30, 2024...

Top News

BREAKING NEWS